𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human osteoblast response to silicon-substituted hydroxyapatite

✍ Scribed by C.M. Botelho; R.A. Brooks; S.M. Best; M.A. Lopes; J.D. Santos; N. Rushton; W. Bonfield


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
495 KB
Volume
79A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Human osteoblasts were cultured on hydroxyapatite (HA), 0.8 wt % silicon substituted hydroxyapatite (Si‐HA) and 1.5 wt % Si‐HA discs. The influence of these substrates on cell behaviour in vitro was assessed by measuring total protein in the cell lysate and the production of several phenotypic markers: collagen type I (COL I), alkaline phosphatase (ALP), osteocalcin (OC), and the formation of bone mineral. After 7 days, β‐glycerophosphate and physiological levels of hydrocortisone were added to the culture medium to stimulate cell differentiation and mineral production. There was a significantly higher production of ALP on 1.5 wt % Si‐HA at day 7 following which, the addition of hydrocortisone promoted the differentiation of cells on the other two substrates. Hydrocortisone addition also decreased the production of OC. During the period, when hydrocortisone was present, no significant difference in behavior was seen between cells on Si‐HA and HA; however, following removal of hydrocortisone, cells responded to 0.8 wt % Si‐HA with a significant increase in protein production. Using fluorescence microscopy, nodular structures labeled with tetracycline were observed on the surface of all substrates after 21 days. These structures were deposited on areas of high cell density but were not related to the presence or level of silicon in the substrate. These results indicate that human osteoblasts are affected by the presence of silicon in the HA substrate and that the timing of these effects may be dependent upon the level of silicon substitution. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006


📜 SIMILAR VOLUMES


Carbonate substituted hydroxyapatite: Re
✍ Gavin Spence; Nelesh Patel; Roger Brooks; Neil Rushton 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract Carbonate substitution within the hydroxyapatite (HA) lattice improves osteoconduction, although the mechanism by which this occurs is unclear. Discs of dense, sintered, phase‐pure HA and AB‐type carbonate substituted hydroxyapatite (CHA) were cultured for 21 days with human CD14+ cells

Comparison of osteoblast responses to hy
✍ Korenori Ogata; Satoshi Imazato; Atsushi Ehara; Shigeyuki Ebisu; Yoshifumi Kinom 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 999 KB

## Abstract Hydroxyapatite/soluble calcium phosphate composites (HAp/SCaP) are novel HAp‐based materials with enhanced solubility that have been developed by annealing HAp in a vacuum. This study compared the effects of HAp and HAp/SCaP on osteoblast proliferation, differentiation, and mineralizati

Fabrication of nanostructured hydroxyapa
✍ Xingyuan Guo; Julie E. Gough; Ping Xiao; Jing Liu; Zhijian Shen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

## Abstract Nano‐sized hydroxyapatite (HA) powders were produced by a hydrothermal method and a precipitation method. Spark plasma sintering (SPS) was used to fabricate nanostructured HA (NHA) using nano‐sized HA powders as a precursor. Conventional sintering was employed to produce microstructured

In vitro osteoblastic response to 30 vol
✍ Y. Zhang; K.E. Tanner; N. Gurav; L. Di Silvio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

## Abstract Hydroxyapatite‐reinforced high‐density polyethylene (HA‐HDPE) composite, as a bone replacement material, has successfully been used clinically as middle ear prostheses and orbital floor implants. The aim of this study was to examine its __in vitro__ biocompatibility in order to develop

Electrophoretic deposition of hydroxyapa
✍ Xingyuan Guo; Julie Gough; Ping Xiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

## Abstract Hydroxyapatite has been successfully deposited onto Fecralloy substrate (a metal alloy with 22% Cr, 4.8% Al) by electrophoretic deposition in an attempt to promote the adhesion between coating and substrate, consequently to extend the lifetime of implants. Fecralloy has the ability to g

Poly-ϵ-caprolactone/hydroxyapatite compo
✍ F. Causa; P. A. Netti; L. Ambrosio; G. Ciapetti; N. Baldini; S. Pagani; D. Marti 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 967 KB

## Abstract Polycaprolactone (PCL), a semicrystalline linear resorbable aliphatic polyester, is a good candidate as a scaffold for bone tissue engineering, due to its biocompatibility and biodegradability. However, the poor mechanical properties of PCL impair its use as scaffold for hard tissue reg